Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial [Coronary Heart Disease]

ConclusionsIntracoronary morphine administration could not reduce myocardial infarct size in ST‐elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.Clinical Trial RegistrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT01738100.

Source: JAHA:Journal of the American Heart Association - April 3, 2017 Category: Cardiology Authors: Gwag, H. B., Kim, E. K., Park, T. K., Lee, J. M., Yang, J. H., Song, Y. B., Choi, J.-H., Choi, S.-H., Lee, S. H., Chang, S.-A., Park, S.-J., Lee, S.-C., Park, S. W., Jang, W. J., Lee, M., Chun, W. J., Oh, J. H., Park, Y. H., Choe, Y. H., Gwon, H.-C., Hahn Tags: Magnetic Resonance Imaging (MRI), Pharmacology, Acute Coronary Syndromes Original Research Source Type: research